Sickle Cell Anemia Testing and Screening Market

Sickle cell  anemia remains a major global health challenge, affecting millions worldwide, particularly in populations of African, Mediterranean, Middle Eastern, and Indian descent. Early and accurate diagnosis through effective testing and screening programs is critical for managing this debilitating genetic disorder. The sickle cell anemia testing and screening market is evolving rapidly, driven by rising disease prevalence, technological innovations, and expanding public health initiatives. Market Size and Growth Trajectory The global sickle cell anemia testing and screening market was valued at approximately USD 468.7 million in 2025 and is forecasted to expand at a compound annual growth rate (CAGR) of around 12.1% to 13.5% between 2025 and 2030. This growth trajectory could push the market size to an estimated USD 829.5 million by 2030 and potentially beyond USD 1 billion, reflecting increased adoption of advanced diagnostic methods and expanded newborn screening pr…